Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
5.17
+0.06 (1.17%)
Jun 9, 2026, 4:00 PM EDT - Market closed
Bausch Health Companies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,312 | 1,325 | 836.89 | - | - | - |
Cash & Short-Term Investments | 1,312 | 1,325 | 836.89 | - | - | - |
Cash Growth | - | 58.32% | - | - | - | - |
Accounts Receivable | 2,191 | 2,351 | 1,491 | 1,998 | 1,790 | 1,775 |
Inventory | 1,601 | 1,629 | 1,111 | 1,544 | 1,090 | 993 |
Other Current Assets | 874 | 852 | 583.94 | 1,092 | 776 | 720 |
Total Current Assets | 5,978 | 6,157 | 4,023 | 5,596 | 4,247 | 5,607 |
Net Property, Plant & Equipment | 2,095 | 2,074 | 1,240 | 1,707 | 1,600 | 1,598 |
Other Intangible Assets | 4,404 | 4,643 | 3,868 | 6,456 | 5,800 | 6,948 |
Goodwill | 9,807 | 11,271 | 7,726 | 11,183 | 11,547 | 12,457 |
Other Long-Term Assets | 2,214 | 2,221 | 1,624 | 2,408 | 2,492 | 2,592 |
Total Assets | 24,498 | 26,366 | 18,482 | 27,350 | 25,686 | 29,202 |
Accounts Payable | 593 | 600 | 410.43 | 719 | 521 | 407 |
Accrued Expenses | 3,037 | 3,344 | 2,431 | 3,133 | 2,988 | 4,791 |
Current Portion of Long-Term Debt | 889 | 225 | 1,863 | 450 | 432 | - |
Current Portion of Leases | 11 | 11 | - | - | - | - |
Total Current Liabilities | 4,530 | 4,180 | 4,705 | 4,302 | 3,941 | 5,198 |
Long-Term Debt | 19,875 | 20,592 | 13,199 | 21,938 | 20,334 | 22,654 |
Long-Term Leases | 20 | 23 | - | - | - | - |
Other Long-Term Liabilities | 1,155 | 1,194 | 802.05 | 1,192 | 1,151 | 1,384 |
Total Long-Term Liabilities | 21,050 | 21,809 | 14,001 | 23,130 | 21,485 | 24,038 |
Total Liabilities | 25,580 | 25,989 | 18,706 | 27,432 | 25,426 | 29,236 |
Common Stock | 10,542 | 10,516 | 7,310 | 10,423 | 10,391 | 10,317 |
Additional Paid-in Capital | 295 | 357 | 163.06 | 214 | 159 | 462 |
Accumulated Other Comprehensive Income | -1,806 | -1,760 | -1,518 | -1,881 | -2,056 | -1,924 |
Retained Earnings | -11,090 | -9,667 | -6,846 | -9,778 | -9,186 | -8,961 |
Total Common Shareholders' Equity | -2,059 | -554 | -891.24 | -1,022 | -692 | -106 |
Minority Interest | 977 | 931 | 666.86 | 940 | 952 | 72 |
Shareholders' Equity | -1,082 | 377 | -224.38 | -82 | 260 | -34 |
Total Liabilities & Equity | 24,498 | 26,366 | 18,482 | 27,350 | 25,686 | 29,202 |
Total Debt | 20,795 | 20,851 | 15,063 | 22,388 | 20,766 | 22,654 |
Net Cash (Debt) | -19,483 | -19,526 | -14,226 | -22,388 | -20,766 | -22,654 |
Net Cash Per Share | -51.99 | -52.07 | -38.66 | -61.35 | -57.37 | -63.12 |
Book Value | -2,059 | -554 | -891.24 | -1,022 | -692 | -106 |
Book Value Per Share | -5.49 | -1.48 | -2.42 | -2.80 | -1.91 | -0.30 |
Tangible Book Value | -16,270 | -16,468 | -12,485 | -18,661 | -18,039 | -19,511 |
Tangible Book Value Per Share | -43.41 | -43.91 | -33.93 | -51.14 | -49.83 | -54.36 |